The Ministry of Health and Family Welfare has announced proposed amendments to the Medical Devices Rules, 2017. These changes aim to simplify and speed up the licensing process for medical devices. The goal is to enhance the ease of doing business and ensure quicker access to quality medical products in the country.
The ministry has released a draft notification in the Official Gazette, inviting public comments on the proposed amendments. The focus is on streamlining regulatory approvals while upholding standards related to the quality, safety, and performance of medical devices.
Medical devices are currently categorized into four risk-based classes under the existing regulatory framework. The amendments target reducing the time taken to grant manufacturing licenses across these categories.
For Class B devices, which include products like blood pressure monitors and pulse oximeters, the proposed timeline for granting manufacturing licenses may be reduced from 140 days to 115 days. Similarly, approval periods for Class C and Class D devices, such as cardiac stents and orthopedic implants, may also be shortened.
The draft amendments aim to introduce defined timelines for each stage of the licensing process, enhancing transparency and efficiency in the regulatory framework. These measures are designed to strengthen the medical devices ecosystem by facilitating faster regulatory approvals while maintaining quality, safety, and performance standards.
The proposed changes are expected to benefit both manufacturers and patients by enabling quicker availability of quality-assured medical devices. The draft notification is now open for public feedback and can be accessed in the Official Gazette and on the website of the Central Drugs Standard Control Organisation.
